Real-Life Study with Alemtuzumab, Kuwait Experience

Authors
Category Primary study
JournalMultiple Sclerosis and Related Disorders
Year 2023
This article has no abstract
Epistemonikos ID: 691c48e23cf2df5189bbf7f459a802454ff28221
First added on: Feb 15, 2025